Conclusions: This consensus-driven multidisciplinary fatty liver disease action agenda
developed by care providers, clinical researchers, and public health and policy experts …

Liver disease poses a substantial burden in Latin America. This burden is primarily
attributed to a high level of alcohol consumption and the increasing prevalence of risk …

Since 1980, the cumulative effort of scientists and health-care stakeholders has advanced
the prerequisites to address metabolic dysfunction-associated steatotic liver disease …

This vision is clear: to end MASLD as a global public health threat. To achieve this, we
collectively call on all stakeholders, including professional societies across the NCD …

We read with great interest the paper by Camilleri and El-Omar '10 reasons that
gastroenterologists and hepatologists should be treating obesity'1 and concur that these …

The prevalence and incidence of NAFLD is rising due to the obesity pandemic, caused by
the widespread availability of ultra-processed foods and the decrease of physical activity …

Conclusions To summarize, while renaming and redefining the disease was needed, the
implementation is not without challenges (Table 1). A more complex classification may add …

Summary The American, European, and Latin American liver societies have proposed a
change in the nomenclature we use to describe alcohol-related liver disease and non …

Nonalcoholic fatty liver disease, hereafter referred to simply as fatty liver disease, is the most
widespread liver disease, with an estimated prevalence of 38% of the global adult …